Items where authors include "Banerji, A."

Article

Aygören-Pürsün, E., Cohn, D.M., Agmon-Levin, N. et al. (38 more authors) (2026) Sebetralstat for on-demand treatment of hereditary angioedema: A pooled analysis of placebo-controlled clinical trials. World Allergy Organization Journal, 19 (7). 101401. ISSN 1939-4551

Banerji, A., Craig, T., Sitz, K. et al. (21 more authors) (2026) Open-label phase 1b/2 trial of navenibart, a long-acting plasma kallikrein inhibitor for hereditary angioedema. The Journal of Allergy and Clinical Immunology, 157 (5). 1127-1135.e6. ISSN 0091-6749

Conference abstract

Yong, P., Craig, T., Christiansen, S. et al. (10 more authors) (2025) PCR170 Patient and Societal Preferences for On-Demand Treatment in Hereditary Angioedema: Estimation of Utility Using a Discrete Choice Experiment. [Conference abstract]

Bernstein, J., Li, H., Yea, C. et al. (5 more authors) (2021) A022 on-demand oral treatment with kvd900 for hae attacks achieves rapid exposure and improves patient outcomes. [Conference abstract]